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Twenty-nine Shiga toxin-producing Escherichia coli (STEC) strains were identified in a collection of 2,607
isolates from patients with diarrhea in Sa˜o Paulo, Brazil, from 1976 to 1999. The STEC strains belonged
mainly to serotypes O111:HNM (HNM, nonmotile) (13 of 29 [44.8%]), O111:H8 (7 of 29 [24%]), and O26:H11
(4 of 29 [13.8%]); stx1 eae (26 of 29 [89.6%]), in combination with either enterohemorrhagic E. coli hlyA (11 of
26 [42%]) or astA (24 of 26 [92.3%]), prevailed. The O111 STEC strains were distinguished by their inability
to decarboxylate lysine. The predominance of STEC O111 and O26 since the late 1970s and the identification
of STEC serotypes O55:H19, O93:H19, and O118:H16 in association with human infections in Brazil are
described for the first time.
Shiga toxin-producing Escherichia coli (STEC) can cause a
broad spectrum of human illness ranging from uncomplicated
diarrhea to hemorrhagic colitis (HC) and hemolytic-uremic
syndrome (HUS) (14). E. coli O157:H7 is by far the most
important STEC serotype in the world and has been associated
with numerous outbreaks and many sporadic cases of HC and
HUS (20). However, infections with other non-O157 STEC
serotypes have been increasingly reported in many countries
(2, 3, 22). Currently more than 100 different non-O157 STEC
serotypes have been isolated from human infections. Unlike
with O157:H7, outbreaks caused by non-O157 STEC have
rarely been reported, and these strains have been more fre-
quently associated with sporadic cases of diarrhea, HC, and
HUS. Moreover, in many countries, non-O157 strains are
more commonly isolated from patients with diarrhea or HUS
than are O157 STEC strains (3, 5, 23). The major virulence
trait of these bacteria is the production of one or more Stx
types (Stx1, Stx2, or Stx2 variants) (20). Additional factors,
produced mainly by strains in straight association with human
disease and collectively referred to as enterohemorrhagic E.
coli (EHEC), include intimin and enterohemolysin (1, 20).
Other putative virulence factors include the enteroaggregative
E. coli heat-stable enterotoxin (EAST-1), encoded by astA
(25), particularly in O157:H7 and O26:H11 strains and in some
other STEC serotypes. In Brazil, the studies conducted so far
that searched for STEC in human diarrheal disease have in-
vestigated a limited number of strains and have described the
isolation of a few non-O157 STEC strains (7, 12, 16). The
isolation of O157:H7 strains from patients with bloody diar-
rhea as well as one with HUS related to O26:H11 infection was
only recently reported in Brazil (15, 19).
The purpose of this study was to search for STEC in a
collection of 2,607 E. coli isolates, most of them belonging to
important serogroups increasingly associated with HUS and
HC in other countries. The main virulence factors, biotypes,
and susceptibility to antimicrobial agents of the STEC strains
identified were characterized.
The E. coli strains studied belonged to the collection of
Instituto Adolfo Lutz, a Central Public Health Laboratory in
Sa˜o Paulo, Brazil, and national center for E. coli serotyping,
and were isolated between 1976 and 1999, mainly from chil-
dren (0 to 5 years old) with diarrhea (2,549 strains); the
remaining 58 E. coli strains were isolated from immunocom-
promised adult patients with diarrhea (mainly human immu-
nodeficiency virus positive) over the same period. Each strain
was derived from one patient. Except for diarrhea, no other
information regarding the clinical aspects of the patients were
available. None of the strains belonging to the enteropatho-
genic E. coli (EPEC) serogroups carried the EAF sequence
(EPEC adherence factor) as assayed by hybridization assays
with a specific DNA probe (13). The remaining strains outside
the EPEC serogroups did not belong to the enteroinvasive E.
coli (EIEC) serogroups, as determined by agglutination assays
with specific antisera (10), and did not produce enterotoxins
characteristic of the enterotoxigenic E. coli (ETEC) category
(20).
The stx1, stx2, eae, EHEC hlyA, and astA sequences were
sought by colony hybridization assays with specific DNA
probes as described previously (13, 28). E. coli strains carrying
stx1 and/or stx2 were tested for cytotoxicity activity by a Vero
cell culture assay (11). The serotypes were determined by stan-
dard agglutination assays using O1 to O173 and H1 to H56
antisera (10), prepared at Institute Adolfo Lutz. Production of
enterohemolysin was determined by the method of Beutin et
al. (1). The detection of fermentation patterns and the lysine
decarboxylation test were performed by standard methods
(6, 10). The susceptibility to antimicrobial agents was deter-
mined by the standard disk diffusion method (21) using the
following antibiotics (Cecon, Centro de Controle e Produtos
para Diagno´stico Ltda, Sa˜o Paulo, Brazil): ampicillin, amika-
cin, cefepime, cefoxitin, tetracycline, gentamicin, ceftazidime,
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ceftriaxone, imipenem, trimethoprim-sulfamethoxazole, to-
bramicin, kanamycin, chloramphenicol, ciprofloxacin, and
streptomycin.
STEC strains were identified in 29 (1.1%) of the 2,607 E. coli
strains analyzed, and the frequency varied among the different
serogroups studied (Table 1). Most (27 of 29 [93%]) of the
STEC strains were isolated from children (45% from infants
aged 0 to 12 months and 34% from children aged 1 to 5 years),
but two of them were from adults. The STEC strains belonged
mainly to serotypes O111:HNM (13 of 29 [44.8%]), O111:H8
(7 of 29 [24%]), and O26:H11 (4 of 29 [13.8%]), but serotypes
O55:H19, O93:H19, O118:H16, and O157:H7 (one strain
each) were also detected (Table 2). The great majority of the
strains (93%) harbored stx1, while the only O157:H7 strain
carried stx2, and the stx1 stx2 genotype was observed in the
O93:H19 strain. Cytotoxin production was confirmed in all
strains containing stx. Except for two strains, all the others
carried eae, and the EHEC hlyA gene was identified in 13
(44.8%) of the 29 strains. Moreover, it could be observed that
STEC strains were isolated in 1976 and in subsequent years,
but no predominance in a particular year was identified (Table
2). Analysis of the biochemical behavior of the STEC strains
showed that all O111 STEC strains fail to decarboxylate lysine
whereas this reaction was positive in the other serotypes iden-
tified. Moreover, lack or delay in fermenting sucrose was ob-
served only in serogroup O111. All strains except the O157
strain fermented sorbitol, and inability to ferment rhamnose
and dulcitol was associated with O26 and O118 strains, which
were also the only ones that fermented sorbose. Resistance to
at least one drug was identified in 51.7% of the STEC strains,
and occurred among strains of serogroups O26 (2 strains),
O111 (12 strains), and O118 (1 strain). However, multidrug
resistance (to three to six drugs) was observed only in serotypes
O111:HNM (four strains) and O111:H8 (one strain). The an-
tibiotics for which resistance was most frequently observed
were tetracycline (93%), streptomycin (73%), kanamycin
(33%), chloramphenicol (20%), and trimethoprim-sulfame-
thoxazole (13%) (either alone or in combination).
In the present study we observed the predominance of O111
and O26 serotypes among STEC strains identified in Sa˜o Paulo
from 1976 through 1999 and described for the first time the
association of other serotypes such as O55:H19, O93:H19, and
O118:H16 with human infections in Brazil. The great majority
of these non-O157 serotypes are among those most frequently
isolated in many different countries (2, 9, 14, 23). In Sa˜o Paulo,
low rates of occurrence O111 STEC strains had previously
been reported (16). Although outbreaks of HUS caused by
O111 strains had been described (4, 5, 8), the O111 STEC
strains identified so far in our settings were all associated with
sporadic cases of diarrhea in young children. Moreover, the
results of this retrospective study and the recent description of
the isolation of a STEC O26:H11 strain associated with HUS
(15) are in contrast to previous reports that described the
nonoccurrence of STEC among O26 strains in Brazil (24, 26,
27).
In many developed countries, O157:H7 is the most prevalent
STEC serotype associated with severe disease in humans (14,
22). However, estimation of the prevalence of O157-associated
infections in Brazil is difficult since screening for O157 is per-
formed by only a few microbiological laboratories. The only
O157:H7 strain found in the present study, isolated in 1990
from a human immunodeficiency virus-positive patient, and
the two other O157:H7 strains that we recently isolated in Sa˜o
Paulo are the only O157:H7 strains identified so far in associ-
ation with human disease in Brazil (19).
In this study stx1 eae prevailed, and an association between
eae and EHEC hlyA was seen among strains of serotypes
O26:H11, O111:H8, O111:NM, O118:H16, and O157:H7. Thus,
considering the serotypes and virulence profiles, these STEC
strains can be classified as EHEC, and it would not be surpris-
ing if some of them had been associated with more severe
diseases. We can only speculate about this possibility, because
TABLE 1. Frequency of STEC among several E. coli serogroups
isolated from patients with diarrheal disease in
Sa˜o Paulo, Brazil, from 1976 to 1999
Serogroupa No. of strainsstudied
No. (%) of
STEC strains
O26 205 4 (1.95)
O55 209 1 (0.48)
O111 802 21 (2.61)
O113 16 0
O119 305 0
O157 15 1 (6.67)
ND 1,055 2 (0.19)
Total 2,607 29 (1.1%)
a ND, undetermined (not belonging to the EPEC, EIEC, and ETEC catego-
ries).





Presence of (no. of strains): Presence of EHEC Hly
(no. of strains)
Yr of isolation
(no. of strains)eae EHEC hlyA astA
O26:H11 (4) 1     1981, 1985, 1987, 1997
O55:H19 (1) 1     1984
O93:H19 (1) 1  2     1984
O111:NM (13) 1   (3)  (12)  (3) 1978 (3), 1980 (2), 1981, 1983, 1985, 1986,
1987, 1988 (2), 1993
O111:H8 (7) 1   (3)  (6)  (2) 1976, 1977, 1979, 1985, 1988, 1993, 1998
O111:H11 (1) 1     1981
O118:H16a (1) 1     1989
O157:H7a (1) 2     1990
a Isolated from adults.
904 NOTES J. CLIN. MICROBIOL.
of the retrospective character of the present study and because
detailed clinical data for the patients are not available.
With regard to the biochemical behavior of the STEC
strains, besides confirming that all STEC O111 strains were
lysine decarboxylase negative, as previously reported by Guth
et al. (16, 17), we observed that this reaction also distinguished
O111 STEC strains from the other STEC serotypes identified.
The inability to decarboxylate lysine and the lack of sucrose
fermentation by the majority of the O111:HNM strains showed
that these strains can be misidentified presumptively as EIEC
or as Shigella. The inability to ferment rhamnose was recently
reported as a characteristic of O26 STEC isolates (18). Nev-
ertheless, among the strains presently identified, O118 as well
as O26 was rhamnose negative. In conclusion, the results of
this study showed that potential EHEC strains, particularly
O111 and O26 strains, have been found in Sa˜o Paulo since the
late 1970s. The implementation of a systematic surveillance of
bloody diarrhea and HUS in Brazil will contribute to estima-
tions of the real association of O157:H7 and non-O157 strains
with human infections.
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